Swiss National Bank
HUMA icon

Swiss National Bank’s Humacyte HUMA Stock Holding History

Swiss National Bank’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-237,900
Closed -$406K – 2366
2025
Q1 		$406K Buy
237,900
+65,800
+38% +$247K ﹤0.01% 2369
2024
Q4 		$869K Buy
172,100
+9,400
+6% +$46.5K ﹤0.01% 2263
2024
Q3 		$885K Buy
+162,700
New +$1.07M ﹤0.01% 2271
2023
Q1 		– Sell
-133,500
Closed -$282K – 2652
2022
Q4 		$282K Hold
133,500
– – ﹤0.01% 2650
2022
Q3 		$435K Hold
133,500
– – ﹤0.01% 2609
2022
Q2 		$429K Buy
133,500
+11,700
+10% +$65K ﹤0.01% 2648
2022
Q1 		$860K Buy
121,800
+8,400
+7% +$48.9K ﹤0.01% 2466
2021
Q4 		$822K Buy
+113,400
New +$1.12M ﹤0.01% 2546

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Swiss National Bank's HUMA Position: Q2 2025 in Review

Swiss National Bank sold out of Humacyte (HUMA) in Q2 2025, closing a stake of 237,900 shares — an estimated $406K sold.

Swiss National Bank first reported a position in HUMA in Q4 2021 and held it in 8 quarters. The position peaked at $885K in Q3 2024. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • Swiss National Bank reported no remaining Humacyte position as of Q2 2025 after selling out during the quarter.
  • Swiss National Bank sold 237,900 Humacyte shares in Q2 2025, an estimated $406K.
  • Swiss National Bank first reported a position in Humacyte in Q4 2021 and held it in 8 quarters.
  • Swiss National Bank's Humacyte position peaked at $885K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on Swiss National Bank's 13F filing for Q2 2025, filed 12 Aug 2025.